Maravai LifeSciences Holdings, Inc. - Class A common stock — movimiento de fondos (NASDAQ:MRVI) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 368.57 M535.98 M126.22 M7.46 M-57.57 M -39.52 M Flujo de caja de las actividades de inversión 105.66 M-267.61 M-122.31 M-24.32 M-31.41 M -12.71 M Flujo de caja de las actividades financieras -159.05 M-187.5 M-61.09 M-235.71 M-16.5 M -66.83 M Flujo de caja libre 368.57 M535.98 M126.22 M7.46 M-70.72 M -51.87 M

Noticias

Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript

Maravai Q1 2026: los ingresos suben un 41% y vuelve la rentabilidad

Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates

All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to Buy

Baxter International (BAX) Tops Q1 Earnings and Revenue Estimates

Maravai LifeSciences Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:MRVI) 2026-02-26

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

Maravai T4 2025: retorno a EBITDA positivo con recortes de costes

Maravai T4 2025: retorno a EBITDA positivo por recortes de costos

Maravai Q4 2025 slides: return to positive EBITDA on cost cuts

Maravai Lifesciences earnings beat by $0.03, revenue topped estimates